Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04906421
What this trial is testing

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Sagimet Biosciences Inc. 168
Post-approval studies (Phase 4)Study completedNCT01002547
What this trial is testing

Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment

Who this might be right for
Nonalcoholic Steatohepatitis
VA Office of Research and Development 105
Not applicableStudy completedNCT03608748
What this trial is testing

Early Detection of Advanced Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseLiver Fibrosis
HaEmek Medical Center, Israel 1,000
Testing effectiveness (Phase 2)Study completedNCT02581085
What this trial is testing

Tocotrienol Against the Progression of End Stage Liver Disease

Who this might be right for
End Stage Liver DiseaseNASH - Nonalcoholic SteatohepatitisNAFLD - Nonalcoholic Fatty Liver Disease
Chandan Sen 110
Testing effectiveness (Phase 2)Looking for participantsNCT07308548
What this trial is testing

A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )

Who this might be right for
NAFLD (Non-alcoholic Fatty Liver Disease)
Hinova Pharmaceuticals Inc. 80
Not applicableNot Yet RecruitingNCT06097338
What this trial is testing

Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF

Who this might be right for
Fatty Liver Disease, Nonalcoholic
Qianfoshan Hospital 200
Testing effectiveness (Phase 2)WithdrawnNCT03291249
What this trial is testing

Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLDT2DM (Type 2 Diabetes Mellitus)
Tiziana Life Sciences LTD
Not applicableActive Not RecruitingNCT05740358
What this trial is testing

Liver Cirrhosis Network Cohort Study

Who this might be right for
CirrhosisCirrhosis, LiverCirrhosis Early+9 more
Northwestern University 1,222
Not applicableStudy completedNCT02383485
What this trial is testing

Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children

Who this might be right for
Overweight and ObesityNon-alcoholic Fatty Liver Disease
Augusta University 175
Not applicableWithdrawnNCT00375349
What this trial is testing

Non Alcoholic Fatty Liver Disease Influence of Statin Therapy

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Shaare Zedek Medical Center
Not applicableStudy completedNCT01317576
What this trial is testing

Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver!

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseObesity
Bram Brouwers 81
Not applicableNot Yet RecruitingNCT07497750
What this trial is testing

Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial

Who this might be right for
Non Alcoholic Fatty Liver Disease
University Hospital, Toulouse 216
Testing effectiveness (Phase 2)Study completedNCT01147523
What this trial is testing

Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverSteatohepatitis
Aristotle University Of Thessaloniki 30
Large-scale testing (Phase 3)Looking for participantsNCT07581951
What this trial is testing

Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH (Non-Alcoholic Steatohepatitis)
Haisco Pharmaceutical Group Co., Ltd. 886
Very early researchActive Not RecruitingNCT06113003
What this trial is testing

The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease

Who this might be right for
HIVNon-Alcoholic Fatty Liver DiseaseMetabolic-Associated Steatotic Liver Disease
Vanderbilt University Medical Center 63
Early research (Phase 1)Looking for participantsNCT05979389
What this trial is testing

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Who this might be right for
NAFLDPCOS
University of California, San Francisco 50
Not applicableStudy completedNCT02044523
What this trial is testing

Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound

Who this might be right for
Hepatitis CHepatitis BNonalcoholic Fatty Liver Disease (NAFLD)+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 108
Not applicableUnknownNCT05358496
What this trial is testing

Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease)

Who this might be right for
NAFLD- Non Alcoholic Fatty Liver Disease
University of L'Aquila 80
Not applicableLooking for participantsNCT06704321
What this trial is testing

Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Valbiotis 70
Testing effectiveness (Phase 2)Study completedNCT04173065
What this trial is testing

Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Viking Therapeutics, Inc. 248
Next Page